|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$161,000
|
N/A
|
National Cancer Institute
|
|
Neural Progenitor Cells as Cancer Therapy Vectors
|
7R01CA113446-04
|
$341,584
|
$341,584
|
Aboody, Karen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$105,573
|
$26,393
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Prospective study of farmers and their families (Agricultural health study)
|
Z01 CP010119-02020
|
$1,233,935
|
$123,393
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$22,311
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Protein Kinase C and GSTP1 interactions in glioma drug resistance
|
1R01CA127872-01A2
|
$316,728
|
$158,364
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Role of Jak3 in Anaplastic Large Cell Lymphoma
|
5K08CA114395-03
|
$136,080
|
$68,040
|
AMIN, HESHAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Children's Oncology Group Statistics and Data Center Grant
|
2U10CA098413-06
|
$5,717,149
|
$5,717,149
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$546,189
|
$546,190
|
Anderson, Lucy
|
CCR (NCI)
|
|
General Descriptive Studies
|
Z01 CP010183-00350
|
$156,344
|
$15,634
|
Anderson, William
|
DCEG (NCI)
|
|
Swedish childhood cancers study
|
Z01 CP010183-00550
|
$2,170
|
$2,170
|
Anderson, William
|
DCEG (NCI)
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
$445
|
Anderson, William
|
DCEG (NCI)
|
|
Childhood Cancers among Children with Birth Defects in California
|
Z01 CP010183-10459
|
$128,276
|
$128,276
|
Anderson, William
|
DCEG (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
Z01 BC 010982
|
$258,071
|
$258,072
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$258,071
|
$129,036
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$258,071
|
$103,229
|
Aplan, Peter
|
CCR (NCI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-04
|
$255,452
|
$255,452
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Mechanisms of PASG-Mediated Senescence in Hematopoietic Development and Leukemia
|
5R01CA120535-02
|
$311,600
|
$311,600
|
ARCECI, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
OPER OF GOVT R&D GOCO FACILITIES
|
N01CO800001-001
|
$148,088,412
|
$4,100,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
Z01 BC 010692
|
$64,298
|
$12,860
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$450,091
|
$112,523
|
Arthur, Diane
|
CCR (NCI)
|
|
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
|
5K08CA123100-03
|
$139,320
|
$139,320
|
ATTIYEH, EDWARD
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
Z01 BC 010997
|
$178,059
|
$35,612
|
Avital, Itzhak
|
CCR (NCI)
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
3R01CA111419-03S1
|
$77,504
|
$77,504
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
5R01CA111419-03
|
$214,682
|
$214,682
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-03
|
$119,402
|
$119,402
|
BAGATELL, ROCHELLE
|
UNIVERSITY OF ARIZONA
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-03
|
$420,766
|
$420,766
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Pten and P13K regulation of growth and neoplasia in the brain
|
9R01CA135554-06A1
|
$399,518
|
$199,759
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Pharmacology of Anticancer Drugs
|
Z01 BC 011080
|
$936,285
|
$842,657
|
Balis, Frank
|
CCR (NCI)
|
|
Anticancer Drug Development for Childhood Cancers
|
Z01 SC 006880
|
$842,657
|
$842,657
|
Balis, Frank
|
CCR (NCI)
|
|
COG studies of gene amplification in rhabdomyosarcoma
|
5R01CA104896-04
|
$417,146
|
$417,146
|
BARR, FREDERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
|
5R01CA098152-06
|
$297,398
|
$297,398
|
BARREDO, JULIO
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$6,699
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Development of cambinol analogues as antilymphoma agents
|
1R01CA129132-01A1
|
$365,200
|
$182,600
|
BEDALOV, ANTONIO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Focal Adhesion Kinase (FAK) in Human Neuroblastoma
|
5K08CA118178-02
|
$134,435
|
$134,435
|
BEIERLE, ELIZABETH
|
UNIVERSITY OF FLORIDA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$8,717
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$3,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$10,037
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$814,924
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$167,853
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-10
|
$537,840
|
$268,920
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$94,815
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
$202,533
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-05
|
$488,086
|
$488,086
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Molecular Profiling and Candidate Gene Analysis in Pediatric Gliomas
|
1R21CA133173-01
|
$222,188
|
$222,188
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$266,860
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Children's Oncology Group Phase 1 / Pilot Consortium
|
5U01CA097452-07
|
$2,483,710
|
$2,483,710
|
Blaney, Susan
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-11
|
$450,518
|
$9,010
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Childhood Cancers for this search: $189,672,374
|